Delivery Order SPE2DB24D1104-SPE2DB24FYBZ2

Award Date 8/22/24
Potential Completion Date 8/23/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $11,108.71 and a period of performance through May 2, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $6,311.56 and a period of performance through May 8, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $6,858.71 and a performance period through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Biktarvy 50-200-25 mg tablets. The contract has a total ceiling value of $24,049.47 and a period of performance ending on April 28, 2025. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The firm-fixed-price contract has a ceiling value of $5,736.33 and a period of performance through May 30, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $16,512.28 and a completion date of September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Biktarvy 50-200-25 mg tablet. The contract has a ceiling value of $3,445.60 and an ultimate completion date of May 5, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $43,363.83 and a performance period ending on April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The contract has a ceiling value of $9,353.85 and a period of performance through May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a specialty pharmaceutical product, with a ceiling value of $7,623.04 and a completion date of December 14, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYBZ2
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The delivery order has a ceiling value of $12,513.88 and an ultimate completion date of August 23, 2024. The order is issued under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.

Generated 11/21/24, 9:35 AM